Stacy Springs named Executive Director, Richard Braatz named Associate Faculty Director. Read the announcement via MIT News HERE.
2022 BioMAN Summit
The 2022 BioMAN Summit on Platform and Process Innovation for ...
Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.
CBI provides integrated solutions to global health
CBI Activities
Collaboration
MIT CBI is home to the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.
Education
MIT CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We have developed a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.
Research
MIT CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.
Latest News & Research
Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have identified a critical quality attribute that potentially allows the development of a rapid and sensitive process analytical technology for sterility....
AZoNano interviews Biomanfacturing@MIT-CBI collaborator Dr. Georgios 'Yorgos' Katsikis, a researcher in the laboratory of Scott Manalis, the Andrew (1956) and Erna Viterbi Professor, Professor of Biological and Mechanical Engineering, about his involvement in new research...
Our Team
CBI’s core strength is in our team’s cross-cutting experience and
expertise in medicine, biology, chemistry, biomanufacturing, academic
& clinical research, economics, engineering, data analytics, regulatory
science and public policy.
expertise in medicine, biology, chemistry, biomanufacturing, academic
& clinical research, economics, engineering, data analytics, regulatory
science and public policy.
Our Members
Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.
